Passage Bio, Inc. (PASG)
4.52
+0.19
(+4.39%)
USD |
NASDAQ |
Aug 28, 16:00
4.57
+0.05
(+1.11%)
After-Hours: 20:00
Passage Bio Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.02M |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.585M |
| March 31, 2025 | 39.63M |
| December 31, 2024 | 13.68M |
| September 30, 2024 | 14.97M |
| June 30, 2024 | 1.048M |
| March 31, 2024 | 25.25M |
| December 31, 2023 | 7.60M |
| September 30, 2023 | 22.45M |
| June 30, 2023 | 13.97M |
| March 31, 2023 | 21.22M |
| December 31, 2022 | -3.358M |
| Date | Value |
|---|---|
| September 30, 2022 | -4.758M |
| June 30, 2022 | 16.00M |
| March 31, 2022 | 17.31M |
| December 31, 2021 | -3.605M |
| September 30, 2021 | -11.56M |
| June 30, 2021 | -10.26M |
| March 31, 2021 | -20.40M |
| December 31, 2020 | -36.55M |
| September 30, 2020 | -135.37M |
| June 30, 2020 | -0.094M |
| March 31, 2020 | -0.099M |
| December 31, 2019 | -0.543M |
| September 30, 2019 | 0.391M |
| June 30, 2019 | -0.657M |
| March 31, 2019 | -0.884M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 41.57M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
| Savara, Inc. | 32.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.181M |
| Free Cash Flow | -33.50M |
| Free Cash Flow Per Share (Quarterly) | -2.861 |
| Free Cash Flow to Equity (Quarterly) | -3.426M |
| Free Cash Flow to Firm (Quarterly) | -9.181M |
| Free Cash Flow Yield | -232.0% |